San Jose, California (PRWEB) April 20, 2012

Follow us on LinkedIn Over the years, hematology instruments and reagents has become an indispensable tool for diagnosis, and continues to maintain a strong position in global health. Currently, automated hematology systems play an important role in transfusion medicine, and facilitate the screening of blood donors and blood control product quality. Over the past year also saw the emergence of a new test for the CHR, CSF, CD61 and CD64. Over the next few years, sales of hematology reagents is expected to increase rapidly. Furthermore, the increase of laboratory automation, together with the importance of accreditation, is expected to stimulate demand even more. Another potential driver of growth include the increase in medical tourism, increasing the number of uninsured individuals, and employment prospects stronger emphasis on pre-employment test. Moreover, the industry overall health diagnostic tests, including hematology, promising significant potential for growth, supported by health reform carried out in various sectors in developed and emerging markets like India and China.

represent the segment of the market leaders in hematology instruments. The demand for hematology analysis is influenced by the development of alternative technologies, such as POC instruments and integrated analysis, advances in products and processes laboratory automation with high efficiency. The market was also affected by the shortage of qualified staff in the clinical laboratory, controlling cost pressures, the question of error reduction and revenue contributions from reagents and consumables. Companies invest large amounts on product development, and offers a more sophisticated, easy to use, precise and efficient system that meets the requirements of hospitals and clinical laboratories. The analysis is currently available for distributed multi-purpose laboratory, since the measurements hematological analyzed using a variety of different techniques.

United States led the global hematology instruments and reagents market. Replacement demand for analysis of hematology in the United States was largely affected by the consolidation of the laboratory, and a growing number of group purchasing organizations. Furthermore, the test volume contract because of the imposition of new standards. U.S. health care market has experienced an increase in the number of previous workshops, the medical office where doctors perform tests in-house. However, since adherence to regulatory guidelines, the number of laboratories has diminished and brought low demand for low-volume analysis. The growth in demand for hematology instruments and reagents are expected to come from the Asia-Pacific, Latin America and other emerging markets. In-vitro diagnostics market in Brazil, China and India has registered significant growth, due to increasing population, economic development, increased health care costs, and better access to private medical care. The third market should be an important driver for growth in vitro diagnostic products, including hematology instruments and reagents, which are supported by a strong technical capability fed by the countries.

hematology analyzer is an important segment of market instruments in hematology / coagulation, as stated by the new market research report on hematology instruments and reagents. Hematology analyzer for today is technologically advanced compared to traditional systems, developed twenty years ago. Companies invest large amounts on product development, and offers a more sophisticated, easy to use, precise and efficient system that meets the requirements of hospitals and clinical laboratories. Flow cytometry is a technique common in the developed world. However, the opportunities in developing countries where cytometry and image analysis is still

.

The global market for hematology instrument is obviously a special player. The competition in this market is based on several factors, including innovation, price, product, service, distribution and promotion strategies. Therefore, the scenario is essentially a call for significant investments in product research and innovation alliance and maintain a strategic competitive advantage. Sysmex, Beckman Coulter, and Abbott Laboratories is a major global market in hematology. Besides the three large companies, including several global market hematology smaller companies. Going forward, the market will likely see an influx of several new businesses, as reforms undertaken by the regions developed and developing, and low barriers to entry. Market, resultantly, will see increased competition as many new products from some of the company.

major players outlined in the report include Abbott Diagnostics Inc., Beckman Coulter Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Diagnostica Stago, Horiba Ltd., Instrumentation Laboratory Inc., Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Sysmex Corp., among others

.

research report titled “Hematology Instruments and Reagents: A Global Strategic Business Report” published by Global Industry Analysts Inc., provides a comprehensive overview of hematology instruments and reagents market, current market trends, key growth drivers , the innovation of new products / launch area recent activity, and profiles of leading participants and niche markets worldwide. The report provides annual sales estimates and projections for global hematology instruments and reagents market for the years 2009 through 2017 for the region, including the U.S., Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Key segments analyzed include Hematology / Coagulation Instruments (hematology analyzers, flow cytometers hematology analyzers, coagulation, Hemoglobinometers, stainers, centrifugal machine, Hematology and Hematology Vials), and Hematology / Coagulation Reagents (Flow Cytometry Reagents, Coagulation Reagents, Hematology Reagents, Immuno – Hematology Reagents, Control plasma, Hematology Stains). This study also provides historical data for understanding the evolution of the market in the period 2003 to 2008.

For more details on the comprehensive report of market research, please visit
http://www.strategyr.com/Hematology_Instruments_And_Reagents_Market_Report.asp

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people around the world. Each year, the GIA has published more than 1300 large-scale research reports and market analysis + 40.000 and technology trends, while the monitoring of over 126 000 companies around the world. With over 9500 customers in 27 countries, GIA is recognized as one of the largest and the famous market research.

Follow us on LinkedIn

Global Industry Analysts, Inc.

Phone: 408-528-9966

Fax: 408-528-9977

-mail: press (at) StrategyR (dot) com

Web Site: http://www.StrategyR.com/

clear = “all”
Find more domestic Press Release For Sale

(PRWeb UK) 17 September 2011

Mustapha Njie, CEO Taf Holdings Company Ltd, praised the increase of foreign investors as a “victory for the Gambia property market.” Investors are snapping up property for sale in Gambia fast.

Gambia, a small village on the west coast of Africa, is a popular tourist destination. Only five hours from the UK, offering almost constant sunshine, tropical beaches and quiet relaxing environment. Tourists flock to Gambia from the UK, Ireland, America and Europe during the year and then there is a demand for rental properties. Gambia property sales are also requests from people looking for holiday homes, start a business, or retire in the Gambia.

Investors have discovered that buying a property in The Gambia makes sense. The country has economic, market-driven liberal and stable political system. Buying and selling real estate in The Gambia is quite easy – this is due to land and property laws are based on the British model, and buy property in Gambia are usually much simpler than many other countries. And, as the property is still relatively cheap, investors re-obtain a high growth of capital, year after year.

One of the leading real estate development in the Gambia Gambia is owned Taf, the Taf Holdings. CEO, Mustapha Njie, said: “We have seen tremendous growth in demand for goods For years we were involved in ‘residential’ to build affordable homes for the Gambia at the same time, we want to attract foreign investors .., and we have developed Brufut Gardens, a development that overlooks the Atlantic Ocean and contains more than five modern apartments, houses and villas. “

have seen excellent results of their investment, but property prices are still very low in Gambia. Mustapha Njie continued: “Properties of the Gambia is available to everyone, whether they are professional investors, families seeking a vacation home, or some who want to retire, however, continue to rise – so now it’s time to go on the boat. ».

Learn more by visiting http://www.tafgambianproperty.com

# # #

clear = “all”